Progenics Pharmaceuticals, Inc. (PGNX) Misses Q3 EPS by 3c
Progenics Pharma
For earnings history and earnings-related data on Progenics Pharmaceuticals, Inc. (PGNX) click here.
ceuticals, Inc. (NASDAQ: PGNX) reported Q3 EPS of ($0.33), $0.03 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.12 million versus the consensus estimate of $2.51 million.
For earnings history and earnings-related data on Progenics Pharmaceuticals, Inc. (PGNX) click here.